Literature DB >> 7104902

The reproducibility of intrapartum cardiotocogram assessments.

M D Beaulieu, J Fabia, B Leduc, J Brisson, A Bastide, D Blouin, R J Gauthier, A Lalonde.   

Abstract

Five obstetrician-gynecologists experienced in fetal monitoring assessed 150 intrapartum cardiotocograms obtained with an external transducer. There were three successive blind readings, the first two without any clinical data apart from gestational age. The reviewers indicated whether the tracings showed definite, possible or no abnormalities. The interpretations given by each reviewer for any one tracing were fairly consistent, but they varied markedly from one reviewer to another. The proportion of tracings interpreted as normal ranged from 39% to 74%, and the proportion assessed as abnormal ranged from 3% to 43%. All five observers agreed on the interpretation of 29% of the tracings. Inter-reviewer reproducibility scarcely changed when clinical data were provided. These findings emphasize the need to evaluate all methods of fetal monitoring before they become widespread.

Mesh:

Year:  1982        PMID: 7104902      PMCID: PMC1861923     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  5 in total

1.  Controlled trial of fetal intensive care.

Authors:  P Renou; A Chang; I Anderson; C Wood
Journal:  Am J Obstet Gynecol       Date:  1976-10-15       Impact factor: 8.661

2.  Observer variability in assessment of antepartum cardiotocograms.

Authors:  J B Trimbos; M J Keirse
Journal:  Br J Obstet Gynaecol       Date:  1978-12

3.  Physicians' subjectivity in evaluating oxytocin challenge tests.

Authors:  T M Peck
Journal:  Obstet Gynecol       Date:  1980-07       Impact factor: 7.661

4.  Predictors of intrapartum fetal distress: the role of electronic fetal monitoring. Report of the National Institute of Child Health and Human Development Consensus Development Task Force.

Authors:  F P Zuspan; E J Quilligan; J D Iams; H P van Geijn
Journal:  Am J Obstet Gynecol       Date:  1979-10-01       Impact factor: 8.661

5.  An assessment of continuous fetal heart rate monitoring in labor. A randomized trial.

Authors:  I M Kelso; R J Parsons; G F Lawrence; S S Arora; D K Edmonds; I D Cooke
Journal:  Am J Obstet Gynecol       Date:  1978-07-01       Impact factor: 8.661

  5 in total
  6 in total

1.  A comparison of subjective and mathematical estimations of fetal heart rate variability.

Authors:  Adam J Wolfberg; David J Derosier; Trevor Roberts; Zeeshan Syed; Gari D Clifford; David Acker; Adre Du Plessis
Journal:  J Matern Fetal Neonatal Med       Date:  2008-02

2.  Randomised controlled trial of cardiotocography versus Doppler auscultation of fetal heart at admission in labour in low risk obstetric population.

Authors:  G Mires; F Williams; P Howie
Journal:  BMJ       Date:  2001-06-16

3.  Indications contributing to the increasing cesarean delivery rate.

Authors:  Emma L Barber; Lisbet S Lundsberg; Kathleen Belanger; Christian M Pettker; Edmund F Funai; Jessica L Illuzzi
Journal:  Obstet Gynecol       Date:  2011-07       Impact factor: 7.661

4.  Fetal heart rate monitoring of short term variation (STV): a methodological observational study.

Authors:  Stina Wretler; Malin Holzmann; Sophie Graner; Pelle Lindqvist; Susanne Falck; Lennart Nordström
Journal:  BMC Pregnancy Childbirth       Date:  2016-03-16       Impact factor: 3.007

5.  Tocolysis and the risk of nonreassuring fetal status among pregnant women in labor: Findings from a population-based retrospective cohort study.

Authors:  I-Te Wang; Meng-Ting Tsai; Steven R Erickson; Chung-Hsuen Wu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

6.  Timing of Histologic Progression from Chorio-Deciduitis to Chorio-Deciduo-Amnionitis in the Setting of Preterm Labor and Preterm Premature Rupture of Membranes with Sterile Amniotic Fluid.

Authors:  Chan-Wook Park; Joong Shin Park; Errol R Norwitz; Kyung Chul Moon; Jong Kwan Jun; Bo Hyun Yoon
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.